Healthcare Private Placement and M&A Transactions Review Week Ending July 10 2022

Immutics: The company raised $100 million of venture funding from undisclosed investors on July 6, 2022. The company is a developer of antibody drugs intended for applications in Immuno oncology and other disease areas.

Calyxo: The company raised $32.7 million of Series C venture funding in a deal led by Questa Capital and CRG on July 6, 2022. The company is a manufacturer of a kidney stone retrieval device intended to remove kidney stone fragments.

Kernal Biologics: The company raised $25 million of Series A venture funding in a deal led by Hummingbird Ventures on July 7, 2022. Amgen Ventures, HBM Genomics, Civilization Ventures, Expanding Capital, Sandy Kory and Amino Collective also participated in the round. The company is a developer of mRNA therapies designed to develop curative immunotherapies for cancers and COVID-19.

Sibel Health: The company raised $25 million of venture funding from undisclosed investors on July 8, 2022. The company is a developer of medical device designed to offer wireless vital sign monitoring to patients and pregnant mothers.

Ganymed Robotics: The company raised EUR 21 million of Series B venture funding in a deal led by Cathay Capital Private Equity on July 7, 2022. BNP Paribas Développement, Crédit Mutuel Innovation, Kurma Partners and other undisclosed investors also participated in the round. The company is a developer of a therapeutic device designed to enhance surgical precision in knee replacement surgery.

Entegrion: The company raised $13.87 million of Series D venture funding from undisclosed investors on July 5, 2022, putting the company’s pre-money valuation at $22.13 million. The company is a developer of diagnostic tools designed for clinical diagnosis and management of hemostasis.

Novasenta: The company raised $10 million of venture funding from an undisclosed investor on July 8, 2022. The company is a developer of a pharmaceutical drug designed to provide immunotherapy treatment for cancer.

MediBeacon: The company raised $8.13 million of venture funding in the form of convertible debt from undisclosed investors on July 8, 2022. The company is a developer of fluorescent tracer-agent-based systems designed to help provide a vital and actionable measurement of organ function.

Element3 Health: The company raised $6 million of Series A venture funding from New Enterprise Associates, Lawrence Leisure and Louis Brandt on July 5, 2022, putting the company’s pre-money valuation at $4 million. Shelby Bryan and Sorenson Impact Foundation also participated in the round. The company is a developer of healthcare engagement platform created to promote health and wellness.

Rakuten Medical: The company raised $5.19 million of venture funding in the form of options and warrants from undisclosed investors on July 7, 2022. The company is a developer of precision-targeted cancer therapies designed to treat solid tumors.

Reglagene: The company closed on $5 million of an undisclosed targeted amount of Series A1 venture funding on July 5, 2022, putting the company’s pre-money valuation at $20 million. The company is an operator of an oncology company intended to discover and develop novel medicines for metastatic cancers.

B-rayZ: The company raised CHF 4 million of Series A venture funding in a deal led by Protagon Group, LifeCare Partners, and Convergence Partners on July 7, 2022. Eckenstein-Geigy-Stiftung and other undisclosed investors also participated in the round. The company is a developer of AI-based software designed to support radiologists in mammography with real-time assessment of image quality and breast density.

Healthera: The company raised an undisclosed amount of venture funding in the form of convertible debt from Serafund and Bob Xiaoping Xu on July 7, 2022. The company is a developer of health management application designed to connect patients with pharmacists.

Soundwave Hearing: The company is in the process of raising venture funding on July 7, 2022. The company is a developer of a hearing device and software platform designed to provide hearing aid.

---

Meridian Bioscience / SD Biosensor: The company reached a definitive agreement to be acquired by SD Biosensor and SJL Partners for an estimated KRW 2.0 trillion on July 7, 2022. The company will no longer be traded or listed on any public securities exchange. Meridian Bioscience Inc is an integrated life science company.

Trans Ova Genetics / URUS: The company, a subsidiary of Precigen, reached a definitive agreement to be acquired by URUS for $180 million on July 5, 2022. The company is an operator of a biotechnology company focused on providing reproductive technologies and expertise to cattle breeders.

Pega Medical / OrthoPediatrics: The company was acquired by OrthoPediatrics for $33 million on July 5, 2022. The company is a developer of osteosynthesis and deformity correction devices designed for patients suffering from osteogenesis imperfecta and other bone deformities.

Tarus Therapeutics / Portage Biotech: The company reached a definitive agreement to be acquired by Portage Biotech for $21 million on July 6, 2022. The company is a provider of cancer therapy biotechnology services focused on nucleotide metabolism in cancer.

Protypia / Inotiv: The company was acquired by Inotiv for $11 million on July 7, 2022. The company is a developer of a targeted proteomics platform designed to precisely quantify drug target systems in cells, tissue models and human tissues.

Ancora Medical / SCILEX Holding Company: The company was acquired by SCILEX Holding Company, a subsidiary of Sorrento Therapeutics, for an undisclosed amount on July 7, 2022. The company is a developer of catheter technology designed to administer long-lasting anesthesia during the preoperative, perioperative and postoperative periods associated with general and orthopedic surgery.

Best Formulations / Sirio Pharma: The company reached a definitive agreement to be acquired by Sirio Pharma for an undisclosed amount on July 7, 2022. The company is an operator of a diversified nutraceutical and pharmaceutical firm intended to develop nutritional supplements.

DiscoveryBioMed / Eurofin Discovery: The company was acquired by Eurofin Discovery for an undisclosed amount on July 5, 2022. The company is a developer of a medical technology platform designed to treat kidney diseases.

DNA GPS Vision / RetinalGenix Technologies: The company was acquired by RetinalGenix Technologies for an undisclosed amount on July 6, 2022. The company is an operator of a pharmacogenetics company based in New Port Richey, Florida.

ExsoMed / Acumed: The company was acquired by Acumed, a subsidiary of Colson Medical, for an undisclosed amount on July 6, 2022. The company is a manufacturer and designer of hand and wrist fracture products designed to facilitate surgical fixation of bones, bone fragments, and osteotomies.

Formatec Technical Ceramics / Nano Dimension: The company was acquired by Nano Dimension for an undisclosed amount on July 8, 2022. The company is a manufacturer of technical ceramic product intended to simplify the production process.

Namocell / Bio-Techne: The company was acquired by Bio-Techne for an undisclosed amount on July 5, 2022. The company is a provider of innovative single-cell sorting and dispensing platforms to empower single-cell research and therapeutics development.

Physicians Immediate Care / WellNow Urgent Care: The company was acquired by WellNow Urgent Care for an undisclosed amount on July 7, 2022. The company is an operator of medical clinics specializing in occupational medicine and urgent care for communities.

Revo Squared / Zomedica Pharmaceuticals: The company was acquired by Zomedica Pharmaceuticals for an undisclosed amount on July 6, 2022. The company is a manufacturer and developer of veterinary imaging systems catering to the needs of clinical veterinarians.

ScalaMed / Cardinal Health: The company was acquired by Cardinal Health for an undisclosed amount on July 7, 2022. The company is an operator of a prescription management application designed to reduce medication-related hospitalizations.

Slu Care / SSM Health: The company was acquired by SSM Health for an undisclosed amount on July 5, 2022. The company is an operator of an academic medical practice intended to deliver medical services across the region.

Tyme Technologies / Syros Pharmaceuticals: The company reached a definitive agreement to be acquired by Syros Pharmaceuticals for an undisclosed amount on July 5, 2022. Tyme Technologies Inc is the U.S based clinical-stage biotechnology company.